Business Context and Reporting Period
This Form 8-K was filed by Shuttle Pharmaceuticals Holdings, Inc. on May 17, 2023. The Company is a Delaware corporation headquartered in Rockville, Maryland, and its common stock trades on The Nasdaq Stock Market LLC under the symbol SHPH. The filing is designated as an "Other Event" (Item 8.01) and identifies the registrant as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates were reported in this filing. The document solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
- Upcoming Event: The Company and its Chief Executive Officer, Dr. Anatoly Dritschilo, will participate in the Lytham Partners Spring 2023 Investor Conference.
- Event Details: The conference is scheduled to take place virtually on May 18, 2023.
- Exhibits: A press release regarding this conference is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the date and time of the Lytham Partners Spring 2023 Investor Conference to ensure attendance or access to the virtual broadcast.
- Review the attached press release (Exhibit 99.1) for any specific topics or presentations planned by management.
- Confirm the Company's status as an emerging growth company and any associated reporting exemptions.